Vifor joins forces with Evotec on kidney disease joint ventureEvotec has teamed up with Swiss pharma company Vifor to create a joint venture that will focus on Share XVifor joins forces with Evotec on kidney disease joint venturehttps://pharmaphorum.com/news/vifor-joins-forces-with-evotec-on-kidney-disease-joint-venture/
Evotec announces potential $850m R&D partnership with TakedaGermany’s Evotec has announced another high-profile R&D partnership with big pharma, beginning a multi-year R&D partnership with Takeda, Share XEvotec announces potential $850m R&D partnership with Takedahttps://pharmaphorum.com/news/evotec-announces-potential-850m-rd-partnership-with-takeda/
Evotec begins new Oxford Uni digital health partnershipGermany’s Evotec has begun a new strategic partnership with the British AI tech company Sensyne Health and Oxford Share XEvotec begins new Oxford Uni digital health partnershiphttps://pharmaphorum.com/news/evotec-begins-new-oxford-uni-digital-health-partnership/
Evotec and Celgene unite to drive forward oncology R&DEvotec and Celgene have joined forces in a long-term strategic drug discovery and development partnership, to identify new Share XEvotec and Celgene unite to drive forward oncology R&Dhttps://pharmaphorum.com/news/evotec-celgene-unite-drive-forward-oncology-rd/
